Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8978 |
High Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8832 |
High Similarity |
NPD4908 |
Phase 1 |
0.8786 |
High Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8786 |
High Similarity |
NPD5124 |
Phase 1 |
0.8321 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8321 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.8311 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8269 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8247 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8205 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8188 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8137 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8029 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7986 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7974 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7973 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7958 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7943 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7931 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7925 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7911 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7911 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7908 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7908 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7885 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7881 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7857 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7834 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7823 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7815 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7808 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7798 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7785 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7762 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7748 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7748 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7736 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7724 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7712 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7707 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7703 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7688 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7682 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7654 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7597 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7591 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7584 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7578 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7568 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.756 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7535 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7532 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7529 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6666 |
Approved |
0.75 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6667 |
Approved |
0.75 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7485 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.747 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7468 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7466 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7466 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7465 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7452 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7451 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7451 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7451 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.744 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7438 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7432 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7419 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7415 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD37 |
Approved |
0.7407 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7405 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7396 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7394 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7383 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7378 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7378 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7378 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7372 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7368 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7351 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7349 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7341 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7341 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7333 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7317 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7312 |
Intermediate Similarity |
NPD920 |
Approved |
0.7308 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7305 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7296 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7296 |
Intermediate Similarity |
NPD2532 |
Approved |
0.729 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.729 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD5763 |
Approved |
0.729 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.729 |
Intermediate Similarity |
NPD5762 |
Approved |
0.729 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7285 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7279 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7278 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7251 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7241 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7237 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7219 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7211 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7209 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7205 |
Intermediate Similarity |
NPD7427 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7197 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7188 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7179 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7168 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7168 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7152 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7125 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7125 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7115 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7115 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7115 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7115 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7115 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7095 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7095 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7093 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7093 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7093 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7088 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7086 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.708 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7075 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7073 |
Intermediate Similarity |
NPD6502 |
Phase 2 |
0.7067 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7066 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7062 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7056 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7052 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7047 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7041
|
Intermediate Similarity |
NPD6746 |
Phase 2 |